Age-associated murine cardiac lesions are attenuated by the mitochondria-targeted antioxidant SkQ1

Histology and Histopathology

Volumn 30, Issue 3, 2015, Pages 353-360

  Manskikh, V N ^a   Gancharova, O S ^a   Nikiforova, A I ^a   Krasilshchikova, M S ^b   Shabalina, I G ^c   Egorov, M V ^a   Karger, E M ^a   Milanovsky, G E ^a   Galkin, I I ^a   Skulachev, V P ^a   Zinovkin, R A ^a  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^c STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

Cardiac hypertrophy; Leukocyte infiltration; Mitochondria targeted antioxidant; Myocardial fibrosis

Indexed keywords

MAMMALIA; MURINAE; MUS;

10-(6'-PLASTOQUINONYL)DECYLTRIPHENYLPHOSPHONIUM; ANTIOXIDANT; PLASTOQUINONE; REACTIVE OXYGEN METABOLITE;

AGING; ANALOGS AND DERIVATIVES; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CARDIOMEGALY; CARDIOMYOPATHIES; CELL COMMUNICATION; DRUG EFFECTS; FEMALE; FIBROSIS; HEART DISEASES; HEART MITOCHONDRION; INFLAMMATION; MALE; METABOLISM; MICROARRAY ANALYSIS; MOUSE; NEUTROPHIL CHEMOTAXIS; PATHOLOGY;

AGING; ANIMALS; ANTIOXIDANTS; CARDIOMEGALY; CARDIOMYOPATHIES; CELL COMMUNICATION; FEMALE; FIBROSIS; HEART DISEASES; INFLAMMATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICROARRAY ANALYSIS; MITOCHONDRIA, HEART; NEUTROPHIL INFILTRATION; PLASTOQUINONE; REACTIVE OXYGEN SPECIES;

EID: 84924336764     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: 10.14670/HH-30.353     Document Type: Article

References (37)

1. Agapova L.S., Chernyak B.V., Domnina L.V., Dugina V.B., Efimenko A.Y., Fetisova E.K., Ivanova O.Y., Kalinina N.I., Khromova N.V., Kopnin B.P., Kopnin P.B., Korotetskaya M.V., Lichinitser M.R., Lukashev A.L., Pletjushkina O.Y., Popova E.N., Skulachev M.V., Shagieva G.S., Stepanova E.V., Titova E.V., Tkachuk V.A., Vasiliev J.M. and Skulachev V.P. (2008). Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 3. Inhibitory effect of skq1 on tumor development from p53-deficient cells. Biochemistry (Mosc) 73, 1300-1316.
2. Anisimov V.N., Egorov M.V., Krasilshchikova M.S., Lyamzaev K.G., Manskikh V.N., Moshkin M.P., Novikov E.A., Popovich I.G., Rogovin K.A., Shabalina I.G., Shekarova O.N., Skulachev M.V., Titova T.V., Vygodin V.A., Vyssokikh M.Y., Yurova M.N., Zabezhinsky M.A. and Skulachev V.P. (2011). Effects of the mitochondria-targeted antioxidant skq1 on lifespan of rodents. Aging (Albany NY) 3, 1110- 1119.
3. Antonenko Y.N., Avetisyan A.V., Bakeeva L.E., Chernyak B.V., Chertkov V.A., Domnina L.V., Ivanova O.Y., Izyumov D.S., Khailova L.S., Klishin S.S., Korshunova G.A., Lyamzaev K.G., Muntyan M.S., Nepryakhina O.K., Pashkovskaya A.A., Pletjushkina O.Y., Pustovidko A.V., Roginsky V.A., Rokitskaya T.I., Ruuge E.K., Saprunova V.B., Severina, II, Simonyan R.A., Skulachev I.V., Skulachev M.V., Sumbatyan N.V., Sviryaeva I.V., Tashlitsky V.N., Vassiliev J.M., Vyssokikh M.Y., Yaguzhinsky L.S., Zamyatnin A.A. Jr and Skulachev V.P. (2008). Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 1. Cationic plastoquinone derivatives: Synthesis and in vitro studies. Biochemistry (Mosc) 73, 1273-1287.
4. Bakeeva L.E., Barskov I.V., Egorov M.V., Isaev N.K., Kapelko V.I., Kazachenko A.V., Kirpatovsky V.I., Kozlovsky S.V., Lakomkin V.L., Levina S.B., Pisarenko O.I., Plotnikov E.Y., Saprunova V.B., Serebryakova L.I., Skulachev M.V., Stelmashook E.V., Studneva I.M., Tskitishvili O.V., Vasilyeva A.K., Victorov I.V., Zorov D.B. and Skulachev V.P. (2008). Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 2. Treatment of some ros- and age-related diseases (heart arrhythmia, heart infarctions, kidney ischemia, and stroke). Biochemistry (Mosc) 73, 1288-1299.
5. Brayton C. (2006). Spontaneous diseases in commonly used strains. In: The mouse in biomedical research. Vol.2. 2nd ed. Fox J. and al. (eds). Elsevier. ACLAM series. pp 623-718.
6. Chung H.Y., Cesari M., Anton S., Marzetti E., Giovannini S., Seo A.Y., Carter C., Yu B.P. and Leeuwenburgh C. (2009). Molecular inflammation: Underpinnings of aging and age-related diseases. Ageing Res. Rev. 8, 18-30.
7. Cieslik K.A., Taffet G.E., Carlson S., Hermosillo J., Trial J. and Entman M.L. (2011). Immune-inflammatory dysregulation modulates the incidence of progressive fibrosis and diastolic stiffness in the aging heart. J. Mol. Cell Cardiol. 50, 248-256.
8. Dai D.F., Santana L.F., Vermulst M., Tomazela D.M., Emond M.J., MacCoss M.J., Gollahon K., Martin G.M., Loeb L.A., Ladiges W.C. and Rabinovitch P.S. (2009). Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging. Circulation 119, 2789-2797.
9. Draghici S., Khatri P., Tarca A.L., Amin K., Done A., Voichita C., Georgescu C. and Romero R. (2007). A systems biology approach for pathway level analysis. Genome Res. 17, 1537-1545.
10. Elwell M.R. and Mahler J.P. (1999). Heart, blood vessels and lymphatic vessels. In: Pathology of the mouse: reference and atlas. Marapont R.R. (ed). Cache River Press. Vienna. pp 361-380.
11. Faccini J.M., Abbott D.P., Paulus G.J.J. and Greaves P. (1990). Mouse histopathology : A glossary for use in toxicity and carcinogenicity studies. Sole distributors for the USA and Canada, Elsevier Science Pub. Co. Amsterdam, New York. pp 65-71.
12. Frith C.N., Goodman D.G. and Boysen B.G. (2007) The mouse, pathology. In: Animal models in toxicology. 2nd ed. Gad S.C. (ed.). Taylor & Francis. Boca Raton. pp 72-122.
13. Graham D., Huynh N.N., Hamilton C.A., Beattie E., Smith R.A., Cocheme H.M., Murphy M.P. and Dominiczak A.F. (2009). Mitochondria-targeted antioxidant mitoq10 improves endothelial function and attenuates cardiac hypertrophy. Hypertension 54, 322- 328.
14. Greaves P. (2007) Histopathology of preclinical toxicity studies. 3rd ed. Elsevier. Amsterdam, New York, Oxford. pp 270-333.
15. Hagiwara A., Tamano S. and Hirose M. (1996). Changes in the heart. In: Pathobiology of aging mouse. Mohr U. (ed). ILSI Press. Washington D.C. pp 361-371.
16. Harman D. (1956). Aging: A theory based on free radical and radiation chemistry. J. Gerontol. 11, 298-300.
17. Lebovitz R.M., Zhang H., Vogel H., Cartwright J. Jr, Dionne L., Lu N., Huang S. and Matzuk M.M. (1996). Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutasedeficient mice. Proc. Natl. Acad. Sci. USA 93, 9782-9787.
18. Li Y., Huang T.T., Carlson E.J., Melov S., Ursell P.C., Olson J.L., Noble L.J., Yoshimura M.P., Berger C., Chan P.H., Wallace D.C. and Epstein C.J. (1995). Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat. Genet. 11, 376-381.
19. Madamanchi N.R. and Runge M.S. (2013). Redox signaling in cardiovascular health and disease. Free Radic. Biol. Med. 61C, 473- 501.
20. Maulik S.K. and Kumar S. (2012). Oxidative stress and cardiac hypertrophy: A review. Toxicol. Mech. Methods 22, 359-366.
21. Muller W.A. (2003). Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol. 24, 327-334.
22. Percy D.H. and Barthold S.W. (2007). Pathology of laboratory rodents and rabbits, 3rd ed. Blackwell Pub. Ames, Iowa. pp 163-164, 202, 214.
23. Price P. and Papadimitriou J.M. (1996). Genetic and immunologic determinants of age-related and virus-induced cardiopathy. In: Pathobiology of aging mouse. Mohr U. (ed). ILSI Press. Washington D.C. pp 373-383.
24. Rodriguez-Cuenca S., Cocheme H.M., Logan A., Abakumova I., Prime T.A., Rose C., Vidal-Puig A., Smith A.C., Rubinsztein D.C., Fearnley I.M., Jones B.A., Pope S., Heales S.J., Lam B.Y., Neogi S.G., McFarlane I., James A.M., Smith R.A. and Murphy M.P. (2010). Consequences of long-term oral administration of the mitochondriatargeted antioxidant mitoq to wild-type mice. Free Radic. Biol. Med. 48, 161-172.
25. Ruben Z., Arceo R.J., Bishop S.P., Elwell M.R., Kerns W.D., Mesfin G.M., Sandusky G.E. and Van Vleet J.F. (1992). Non-proliferative lesions of the heart and vasculature in rat. In: Guides for toxicologic pathology. STP/ARP/AFIP. Washington DC.
26. Schulte D., Kuppers V., Dartsch N., Broermann A., Li H., Zarbock A., Kamenyeva O., Kiefer F., Khandoga A., Massberg S. and Vestweber D. (2011). Stabilizing the ve-cadherin-catenin complex blocks leukocyte extravasation and vascular permeability. EMBO J. 30, 4157-4170.
27. Shioi T. and Inuzuka Y. (2012). Aging as a substrate of heart failure. J. Cardiol. 60, 423-428.
28. Skulachev M.V., Antonenko Y.N., Anisimov V.N., Chernyak B.V., Cherepanov D.A., Chistyakov V.A., Egorov M.V., Kolosova N.G., Korshunova G.A., Lyamzaev K.G., Plotnikov E.Y., Roginsky V.A., Savchenko A.Y., Severina, II, Severin F.F., Shkurat T.P., Tashlitsky V.N., Shidlovsky K.M., Vyssokikh M.Y., Zamyatnin A.A., Jr., Zorov D.B. and Skulachev V.P. (2011). Mitochondrial-targeted plastoquinone derivatives. Effect on senescence and acute agerelated pathologies. Curr. Drug Targets 12, 800-826.
29. Son W.C. (2003). Factors contributory to early death of young cd-1 mice in carcinogenicity studies. Toxicol. Lett. 145, 88-98.
30. Sopel M.J., Rosin N.L., Lee T.D. and Legare J.F. (2011). Myocardial fibrosis in response to angiotensin ii is preceded by the recruitment of mesenchymal progenitor cells. Lab. Invest. 91, 565-578.
31. Taylor I. (2012) Mouse. In: Background lesions in laboratory animals. McInnes E.F. (ed). Saunders Elsevier Ltd. pp 45-72.
32. Tepass U., Truong K., Godt D., Ikura M. and Peifer M. (2000). Cadherins in embryonic and neural morphogenesis. Nat. Rev. Mol. Cell Biol. 1, 91-100.
33. Tsutsui H., Kinugawa S. and Matsushima S. (2011). Oxidative stress and heart failure. Am. J. Physiol. Heart Circ. Physiol. 301, H2181- 2190.
34. Wittchen E.S., Worthylake R.A., Kelly P., Casey P.J., Quilliam L.A. and Burridge K. (2005). Rap1 gtpase inhibits leukocyte transmigration by promoting endothelial barrier function. J. Biol. Chem. 280, 11675- 11682.
35. Zeisberg E.M., Tarnavski O., Zeisberg M., Dorfman A.L., McMullen J.R., Gustafsson E., Chandraker A., Yuan X., Pu W.T., Roberts A.B., Neilson E.G., Sayegh M.H., Izumo S. and Kalluri R. (2007). Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 13, 952-961.
36. Zhang D.X. and Gutterman D.D. (2007). Mitochondrial reactive oxygen species-mediated signaling in endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 292, H2023-2031.
37. Zinovkin R.A., Romaschenko V.P., Galkin I.I., Zakharova V.V., Pletjushkina O.Y., Chernyak B.V. and Popova E.N. (2014). Role of mitochondrial reactive oxygen species in age-related inflammatory activation of endothelium. Aging (Albany NY). 6, 661-674.